Centene Corporation 8-K Filing

Centene Corporation announced its participation in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026. Management will discuss the company's business and financial results, reaffirming its full-year 2026 GAAP diluted EPS guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4.80. The company is providing non-GAAP financial measures to offer investors a clearer assessment of ongoing operations and performance consistency. These measures exclude items like amortization of acquired intangible assets and acquisition/divestiture expenses, which are detailed in a prior filing. The report also includes forward-looking statements regarding future performance, subject to various risks and uncertainties, and clarifies that the provided guidance is effective only until September 25, 2026.